文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

脑递送中的天然多糖载体:挑战与展望

Natural Polysaccharide Carriers in Brain Delivery: Challenge and Perspective.

作者信息

Curcio Manuela, Cirillo Giuseppe, Rouaen Jourdin R C, Saletta Federica, Nicoletta Fiore Pasquale, Vittorio Orazio, Iemma Francesca

机构信息

Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende (CS), Italy.

Lowy Cancer Research Centre, Children's Cancer Institute, UNSW Sydney, Sydney 2031, NSW, Australia.

出版信息

Pharmaceutics. 2020 Dec 6;12(12):1183. doi: 10.3390/pharmaceutics12121183.


DOI:10.3390/pharmaceutics12121183
PMID:33291284
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7762150/
Abstract

Targeted drug delivery systems represent valuable tools to enhance the accumulation of therapeutics in the brain. Here, the presence of the blood brain barrier strongly hinders the passage of foreign substances, often limiting the effectiveness of pharmacological therapies. Among the plethora of materials used for the development of these systems, natural polysaccharides are attracting growing interest because of their biocompatibility, muco-adhesion, and chemical versatility which allow a wide range of carriers with tailored physico-chemical features to be synthetized. This review describes the state of the art in the field of targeted carriers based on natural polysaccharides over the last five years, focusing on the main targeting strategies, namely passive and active transport, stimuli-responsive materials and the administration route. In addition, in the last section, the efficacy of the reviewed carriers in each specific brain diseases is summarized and commented on in terms of enhancement of either blood brain barrier (BBB) permeation ability or drug bioavailability in the brain.

摘要

靶向给药系统是增强治疗药物在大脑中蓄积的重要工具。在此,血脑屏障的存在严重阻碍了外来物质的通过,常常限制了药物治疗的效果。在用于开发这些系统的大量材料中,天然多糖因其生物相容性、粘膜粘附性和化学多功能性而越来越受到关注,这些特性使得能够合成具有定制物理化学特性的多种载体。本综述描述了过去五年基于天然多糖的靶向载体领域的研究现状,重点关注主要的靶向策略,即被动和主动转运、刺激响应材料以及给药途径。此外,在最后一部分,对所综述的载体在每种特定脑部疾病中的疗效进行了总结,并就其增强血脑屏障(BBB)渗透能力或脑部药物生物利用度方面进行了评论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/4e96d2273445/pharmaceutics-12-01183-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/d18693a8e93a/pharmaceutics-12-01183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/443a955276aa/pharmaceutics-12-01183-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/e15b6ea9c5cd/pharmaceutics-12-01183-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/959efb1e6602/pharmaceutics-12-01183-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/c6d429d0b739/pharmaceutics-12-01183-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/6d07c4c73423/pharmaceutics-12-01183-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/4e96d2273445/pharmaceutics-12-01183-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/d18693a8e93a/pharmaceutics-12-01183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/443a955276aa/pharmaceutics-12-01183-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/e15b6ea9c5cd/pharmaceutics-12-01183-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/959efb1e6602/pharmaceutics-12-01183-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/c6d429d0b739/pharmaceutics-12-01183-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/6d07c4c73423/pharmaceutics-12-01183-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d8/7762150/4e96d2273445/pharmaceutics-12-01183-g007.jpg

相似文献

[1]
Natural Polysaccharide Carriers in Brain Delivery: Challenge and Perspective.

Pharmaceutics. 2020-12-6

[2]
In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.

Mol Pharm. 2012-5-7

[3]
Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders.

Adv Drug Deliv Rev. 2022-10

[4]
Micro-Nanocarriers Based Drug Delivery Technology for Blood-Brain Barrier Crossing and Brain Tumor Targeting Therapy.

Small. 2022-11

[5]
Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.

Part Fibre Toxicol. 2010-3-3

[6]
Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting.

J Control Release. 2020-5-10

[7]
Anti-Cancer Drug Delivery Using Carbohydrate-Based Polymers.

Curr Pharm Des. 2018-2-12

[8]
Progress and prospects of polysaccharide-based nanocarriers for oral delivery of proteins/peptides.

Carbohydr Polym. 2023-7-15

[9]
Emerging strategies to fabricate polymeric nanocarriers for enhanced drug delivery across blood-brain barrier: An overview.

Adv Colloid Interface Sci. 2023-10

[10]
Current Advances in Multifunctional Nanocarriers Based on Marine Polysaccharides for Colon Delivery of Food Polyphenols.

J Agric Food Chem. 2022-2-2

引用本文的文献

[1]
Rational Design of Pectin-Chitosan Polyelectrolyte Nanoparticles for Enhanced Temozolomide Delivery in Brain Tumor Therapy.

Biomedicines. 2024-6-23

[2]
Micro- and Nanostructured Fibrous Composites via Electro-Fluid Dynamics: Design and Applications for Brain.

Pharmaceutics. 2024-1-19

[3]
Hyaluronic Acid Conjugated with 17β-Estradiol Effectively Alleviates Estropause-Induced Cognitive Deficits in Rats.

Int J Mol Sci. 2023-10-25

[4]
Polysaccharide-Based Nanogels to Overcome Mucus, Skin, Cornea, and Blood-Brain Barriers: A Review.

Pharmaceutics. 2023-10-23

[5]
Facile one-pot hydrothermal synthesis of a zinc oxide/curcumin nanocomposite with enhanced toxic activity against breast cancer cells.

RSC Adv. 2023-9-11

[6]
Preparation and Characterization of Hydrogel Films and Nanoparticles Based on Low-Esterified Pectin for Anticancer Applications.

Polymers (Basel). 2023-8-2

[7]
The blood-brain barrier: structure, regulation, and drug delivery.

Signal Transduct Target Ther. 2023-5-25

[8]
Membrane Vesicles Derived from Gut Microbiota and Probiotics: Cutting-Edge Therapeutic Approaches for Multidrug-Resistant Superbugs Linked to Neurological Anomalies.

Pharmaceutics. 2022-11-3

[9]
Crosslinked Chitosan-Gelatin Biocompatible Nanocomposite as a Neuro Drug Carrier.

ACS Omega. 2022-5-26

[10]
Polymeric Biomaterials for the Treatment of Cardiac Post-Infarction Injuries.

Pharmaceutics. 2021-7-7

本文引用的文献

[1]
Carboxymethyl cellulose coated magnetic nanoparticles transport across a human lung microvascular endothelial cell model of the blood-brain barrier.

Nanoscale Adv. 2018-10-16

[2]
Overcoming the Blood-Brain Barrier: Functionalised Chitosan Nanocarriers.

Pharmaceutics. 2020-10-23

[3]
Synthesis and characterization of novel chitosan-dopamine or chitosan-tyrosine conjugates for potential nose-to-brain delivery.

Int J Pharm. 2020-11-15

[4]
A Reevaluation of Chitosan-Decorated Nanoparticles to Cross the Blood-Brain Barrier.

Membranes (Basel). 2020-8-30

[5]
Tumor Responsive and Tunable Polymeric Platform for Optimized Delivery of Paclitaxel to Treat Glioblastoma.

ACS Appl Mater Interfaces. 2020-4-29

[6]
Engineering butylglyceryl-modified polysaccharides towards nanomedicines for brain drug delivery.

Carbohydr Polym. 2020-2-21

[7]
RETRACTED: Quantification and Evaluations of Catechin Hydrate Polymeric Nanoparticles Used in Brain Targeting for the Treatment of Epilepsy.

Pharmaceutics. 2020-2-27

[8]
Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances.

Asian J Pharm Sci. 2019-9

[9]
Intranasal administration of carbamazepine-loaded carboxymethyl chitosan nanoparticles for drug delivery to the brain.

Asian J Pharm Sci. 2018-1

[10]
Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson's disease.

Int J Pharm. 2020-2-19

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索